Integra Lifesciences IART
Integra Lifesciences Holdings Corp · Nasdaq · Surgical & Medical Instruments & Apparatus
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
No open-market insider buying or selling in the Form 4s filed since July 24, 2026.
Recent SEC filings
All 11 →Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedIntegra LifeSciences Q3 2026 revenue rises 2.3% to $411.2 million; GAAP EPS $0.19 and adjusted EPS $0.59 beat prior year, but Q4 guidance implies a decline
Entry into a material definitive agreement · Termination of a material definitive agreement · Creation of a direct financial obligation · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedIntegra LifeSciences Refinances Existing Debt with $450 Million 9.5% Senior Secured Notes and a $1.65 Billion Credit Facility
Regulation FD disclosure · Financial statements and exhibits
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
Regulation FD disclosure · Financial statements and exhibits